Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Cancer Type/Condition:
Skin cancer, nonmelanomatous (squamous and basal cell)
Stage/Subtype:
basal cell carcinoma of the skin
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
H-2007-0252
, PRMC_CO08303, NCT00994240
2.
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
PEP005-009
, NCT00432185
3.
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
NCI
Protocol IDs:
CHORI-2007-016
, UCSF-05862, R01-CA-109584, NCT00489086, 05862
4.
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
DUSA-PDT-BCC-06
, DUSA-PDT-BCC-06, NCT00747903
5.
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 - 75
Sponsor:
NCI
Protocol IDs:
CHORI-2007-022
, 05862, CHORI-H473-26042, NCT00783965
6.
A Study Evaluating the Efficacy and Safety of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SHH4476g
, NCT00833417
7.
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
DUSA-CP0104
, NCT00865878
8.
Comparison of Standard of Care or Treatment on Protocol
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
INST 0813
, NCT01010334
9.
Electronic Brachytherapy for the Treatment of NMSC
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
50 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CTPR-0002
, NCT01016899
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
